73 related articles for article (PubMed ID: 1868459)
1. Inhibition of growth of mouse leukemic cell lines in vitro and in vivo by a monoclonal antibody that recognizes an interleukin 3 receptor-associated protein.
Tweardy DJ; Morel PA; Herberman RB; Sakurai M
Cancer Res; 1991 Aug; 51(16):4355-9. PubMed ID: 1868459
[TBL] [Abstract][Full Text] [Related]
2. Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptor.
Tweardy DJ; Morel PA; Mott PL; Glazer EW; Zeh HJ; Sakurai M
Blood; 1992 Jul; 80(2):359-66. PubMed ID: 1378315
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel protein capable of interacting with the IL-3 receptor.
Morel PA; Schreurs J; Townsend K; Gross M; Chiller JM; Tweardy DJ
J Immunol; 1991 Apr; 146(7):2295-304. PubMed ID: 2005398
[TBL] [Abstract][Full Text] [Related]
4. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
5. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD
Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226
[TBL] [Abstract][Full Text] [Related]
7. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
8. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
10. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
12. IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells.
Chiu CP; Lee F
J Immunol; 1989 Mar; 142(6):1909-15. PubMed ID: 2784140
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of the IL-3-dependent NFS-60 cell line and adaption to growth in macrophage colony-stimulating factor.
Nakoinz I; Lee MT; Weaver JF; Ralph P
J Immunol; 1990 Aug; 145(3):860-4. PubMed ID: 2142710
[TBL] [Abstract][Full Text] [Related]
14. Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.
Kupper T; Horowitz M; Lee F; Robb R; Flood PM
J Immunol; 1987 Jun; 138(12):4280-7. PubMed ID: 2953803
[TBL] [Abstract][Full Text] [Related]
15. Concanavalin A-stimulated rat spleen cells produce a soluble factor that supports growth of the mouse IL-3-dependent cell line Ea3.123, but not three other IL-3-dependent lines.
Carron JA; Marshall-Clarke S
Immunology; 1986 Aug; 58(4):635-40. PubMed ID: 3089920
[TBL] [Abstract][Full Text] [Related]
16. Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines.
Onozaki K; Akiyama Y; Okano A; Hirano T; Kishimoto T; Hashimoto T; Yoshizawa K; Taniyama T
Cancer Res; 1989 Jul; 49(13):3602-7. PubMed ID: 2786454
[TBL] [Abstract][Full Text] [Related]
17. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines.
Posner MR; Cavacini LA; Upton MP; Tillman KC; Gornstein ER; Norris CM
Clin Cancer Res; 1999 Aug; 5(8):2261-70. PubMed ID: 10473114
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular biology of interleukin-3.
Morris CF; Young IG; Hapel AJ
Immunol Ser; 1990; 49():177-214. PubMed ID: 2090251
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of hexose uptake by haemopoietic cell growth factor occurs in WEHI-3B myelomonocytic leukaemia cells: a possible mechanism for loss of growth control.
Whetton AD; Bazill GW; Dexter TM
J Cell Physiol; 1985 Apr; 123(1):73-8. PubMed ID: 3882726
[TBL] [Abstract][Full Text] [Related]
20. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
